The global next generation sequencing (NGS) market was valued at USD 10.15 billion in 2024 and is projected to grow at a CAGR of 13.8% to reach USD 32.58 billion by 2034. This growth is driven by government funding, technological advancements, and the rising demand for personalized medicin